CN Patent

CN101198333A — 芳烷基酸衍生物及其用途

Assigned to Bayer Pharmaceuticals Corp · Expires 2008-06-11 · 18y expired

What this patent protects

本发明涉及用于治疗或预防肥胖病和相关病症的芳基烷基酸化合物、组合物和方法。

USPTO Abstract

本发明涉及用于治疗或预防肥胖病和相关病症的芳基烷基酸化合物、组合物和方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN101198333A
Jurisdiction
CN
Classification
—
Expires
2008-06-11
Drug substance claim
No
Drug product claim
No
Assignee
Bayer Pharmaceuticals Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.